Articles By Rob Wright, Chief Editor 2011-2021

How DCAT Is Helping To Sharpen Your Pharmaceutical Sourcing Saw
By Rob WrightChief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL
Friday, July 19, 2013
Traditionally, procurement is viewed as the acquisition of goods and services from an external source with a focus on obtaining the best possible cost. By Rob Wright  Continue Reading..
  • Details Of Dr. Oz Ambush Dished Up During 2013 DIA
    7/15/2013

    At this year’s DIA meeting in Boston, we tried something a little different, thanks to an idea presented to us by LabCorp, which approached us expressing interest in creating an educational/networking opportunity. By Rob Wright

  • Is Closing Your Manufacturing Plant The Best Option?
    7/9/2013

    This year there have been a number of companies announcing pharmaceutical manufacturing plant closures. For example, Catalent Pharma Solutions announced the closing of its Allendale, NJ, facility. Solgar Inc., a subsidiary of NBTY, announced the closing of its plant in Lyndhurst, NJ. These pharma manufacturing plant closings equate to 196 jobs lost for New Jersey.

  • A Life Science Revolution Is Happening Now
    7/2/2013

    To me, it seemed fitting that this year’s annual DIA meeting (June 23 – 27) was held in Boston, a city synonymous with the American Revolution. By Rob Wright

  • 0713_Feature_janssen_pic
    J&J’s Approach To Drug Discovery And Breakthrough Therapy
    7/1/2013

    One year ago, the Food and Drug Administration Safety and Innovation Act (FDASIA) was signed into law. Its most current version includes a provision that allows sponsor companies to request their drug be designated as a “breakthrough therapy.” In February, Johnson & Johnson (J&J) became only the second company (behind Vertex Pharmaceuticals) to have a drug receive this designation.

  • The Secret To True Strategic Partnerships
    6/24/2013

    In the May 2013 issue of Life Science Leader magazine, Wayne Koberstein wrote an article asking the question, When Does a Supplier Become A Partner? I shared Koberstein’s skepticism when he said, “Just doing business with a developer doesn’t make you a partner. By Rob Wright

  • When Was The Last Time You Worked On The Front Lines
    6/10/2013

    When I met Jeff Williams, CEO of Clinipace, the intent was to learn about the business. But in so doing, my natural curiosity got the best of me — inquiring how he got started in the business. By Rob Wright

  • 0613_From The_pic
    Can Pharma And Biotech Companies Trust Emerging Markets To Protect IP?
    5/30/2013

    How long can or should biotech and pharmaceutical companies continue to conduct business in regions where there is government-enabled IP theft?

  • 0613_Feature
    MedImmune’s Blueprint For Building A Biologics R&D Engine
    5/30/2013

    Bahija Jallal, VP of translational science for MedImmune, has some insights on how to successfully focus your biologics R&D operation to encourage, not kill the entrepreneurial spirit on which it was built.

  • The Most Creative Collaborations In Healthcare
    5/28/2013

    This was the question I posed to the panel members of the DSM-sponsored Healthcare Businesswomen’s Association (HBA) Metro Chapter program entitled Creative Collaborations in Healthcare. By Rob Wright

Rob Wright author page

Rob Wright

Rob Wright was chief editor of Life Science Leader magazine from 2011-2021. Prior to joining the publication, he spent nearly 20 years in the pharmaceutical industry. During his industry career, Wright conducted well over 1,000 presentations and roundtable discussions, including the facilitation of FDA-mandated clinical training programs for hundreds of licensed healthcare providers. He has chaired, moderated, and served as a speaker at industry and academic conferences, and served as co-chair for the 2015 and 2018 BIO International conference’s educational planning committee. Wright’s 500+ published articles have appeared in peer-reviewed academic journals, B2B magazines and online publications. He received a B.S. in Business Administration from Indiana University of Pennsylvania, MBA with distinction from Gannon University, and completed his doctoral coursework in marketing at Cleveland State University. He is a member of international business honor societies Sigma Beta Delta and Beta Gamma Sigma. He can be followed on Twitter @RfwrightLSL